Detalles de la búsqueda
1.
Assessment of the burden of disease for patients with peripheral artery disease undergoing revascularization in England.
Vasc Med
; 27(5): 440-449, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35670290
2.
Temporal trends in the incidence, treatment patterns, and outcomes of coronary artery disease and peripheral artery disease in the UK, 2006-2015.
Eur Heart J
; 41(17): 1636-1649, 2020 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31883328
3.
Cost-effectiveness analysis comparing single-pill combination of perindopril/amlodipine/indapamide to the free equivalent combination in patients with hypertension from an Italian national health system perspective.
Expert Rev Pharmacoecon Outcomes Res
; : 1-9, 2024 Jun 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38848115
4.
Impact of poor medication adherence on clinical outcomes and health resource utilization in patients with hypertension and/or dyslipidemia: systematic review.
Expert Rev Pharmacoecon Outcomes Res
; 24(1): 143-154, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37862440
5.
Systematic review and network meta-analysis of agomelatine for the treatment of generalized anxiety disorder in adult patients.
Int Clin Psychopharmacol
; 2024 May 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38804215
6.
The impact of non-pharmacological interventions on adherence to medication and persistence in dyslipidaemia and hypertension: a systematic review.
Expert Rev Pharmacoecon Outcomes Res
; : 1-10, 2024 Feb 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38366854
7.
Ivabradine in patients with heart failure: a systematic literature review.
J Mark Access Health Policy
; 11(1): 2262073, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37808119
8.
Impact of single-pill combinations versus free-equivalent combinations on adherence and persistence in patients with hypertension and dyslipidemia: a systematic literature review and meta-analysis.
Expert Rev Pharmacoecon Outcomes Res
; : 1-11, 2023 Dec 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38088763
9.
Real-world cost-effectiveness analysis of NOACs versus VKA for stroke prevention in Spain.
PLoS One
; 17(4): e0266658, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35443000
10.
Real-world cost-effectiveness of rivaroxaban and apixaban vs VKA in stroke prevention in non-valvular atrial fibrillation in the UK.
J Mark Access Health Policy
; 8(1): 1782164, 2020 Jun 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-32944199
11.
Use of real-world evidence in meta-analyses and cost-effectiveness models.
J Med Econ
; 23(10): 1053-1060, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32657189
12.
Systematic Literature Review of Randomized Trials Comparing Antithrombotic Therapy Following Revascularization Procedures in Patients With Peripheral Artery Disease.
Angiology
; 71(9): 773-790, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32638610
13.
Cost-Effectiveness of Coronary and Peripheral Artery Disease Antithrombotic Treatments in Finland.
Adv Ther
; 37(7): 3348-3369, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32519113
14.
Economic burden of coronary artery disease or peripheral artery disease in patients at high risk of ischemic events in the French setting: a claims database analysis.
J Med Econ
; 23(5): 513-520, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-31928390
15.
Antithrombotic Treatments in Patients with Chronic Coronary Artery Disease or Peripheral Artery Disease: A Systematic Review of Randomised Controlled Trials.
Cardiovasc Ther
; 2020: 3057168, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32695228
16.
Real-world cost-effectiveness of rivaroxaban compared with vitamin K antagonists in the context of stroke prevention in atrial fibrillation in France.
PLoS One
; 15(1): e0225301, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-31978044
17.
A Targeted Literature Review of the Disease Burden in Patients With Symptomatic Peripheral Artery Disease.
Angiology
; 71(4): 303-314, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-31884807
18.
Health economic evaluation of rivaroxaban in the treatment of patients with chronic coronary artery disease or peripheral artery disease.
Cardiovasc Res
; 116(11): 1918-1924, 2020 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31807773
19.
Number needed to treat based on real-world evidence for non-vitamin K antagonist oral anticoagulants versus vitamin K antagonist oral anticoagulants in stroke prevention in patients with non-valvular atrial fibrillation.
J Med Econ
; 22(8): 760-765, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-30969801
20.
Burden of Coronary Artery Disease and Peripheral Artery Disease: A Literature Review.
Cardiovasc Ther
; 2019: 8295054, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-32099582